晚期原发性肝癌系统治疗的研究进展

Research Progress of Systematic Therapy for Advanced Primary Liver Cancer

原发性肝癌是进展快、预后差的癌症,严重危害人体健康。近年来,肝癌的治疗发生了迅速的变化,出现许多治疗药物和新的治疗技术。免疫检查点抑制剂和抗血管生成靶向药物构成了系统治疗的核心,为晚期肝癌患者提供全新的治疗方案。故本文对免疫疗法和分子靶向药物在肝癌治疗领域的进展予以综述。

Primary liver cancer is a cancer with rapid progress and poor prognosis, which is seriously harmful to human health. In recent years, the treatment of liver cancer has changed rapidly, with the emer-gence of many therapeutic drugs and new therapeutic techniques. Immune checkpoint inhibitors and anti-angiogenic targeted drugs constitute the core of systematic therapy, providing a new treatment for patients with advanced liver cancer. Therefore, the progress of immunotherapy and molecular targeted drugs in the treatment of liver cancer is reviewed in this paper.